Millipore Sigma Vibrant Logo

530070 Pristimerin - CAS 1258-84-0 - Calbiochem

A cell-permeable plant dienone-phenolic triterpenoid, naturally isolated from tripterygium wilfordii.

Pristimerin - CAS 1258-84-0 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Monoacylglycerol Lipase Inhibitor II, Proteasome Inhibitor XV, NF-κB Activation Inhibitor IX, MAGL Inhibitor II

View Products on Sigmaaldrich.com
530070
가격 및 재고 조회

개요

Replacement Information

주요 사양표

CAS #Empirical Formula
1258-84-0C₃₀H₄₀O₄

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
530070-5MGCN
재고 정보 검색...
—
현재 재고 없음 현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      		 Plastic ampoule 5 mg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      —
      가격 문의
      		 —
      Description
      OverviewA cell-permeable plant dienone-phenolic triterpenoid, naturally isolated from tripterygium wilfordii, whose inhibitory activities against proteasome chymotrypsin subunit (IC50 = 2.2 and 3.0 µM against purified rabbit 20S and human 26S proteasome, respectively) and cellular NF-κB pathway/IKK activation most likely account for its reported anticancer efficacy both in vitro (IC50 ≤610 nM in A549, K562, KBM5, MCF-7, MDA-MB-231, HepG2, and primary human leukemia cell cultures) and in mice in vivo (1 to 2.5 mg/kg/day, s.c.), including imatinib/STI571-resistant cancer cells harboring Bcr-Abl T315I mutation. Also reported to inhibit the activity of monoacylglycerol lipase (MGL), the enzyme that hydrolyzes and deactivates the cannabionoid receptor ligand 2-Arachidonoyl-sn-glycerol (2-AG), in a reversible manner with high potency (IC50 = 93 nM).
      Catalogue Number530070
      Brand Family Calbiochem®
      SynonymsMonoacylglycerol Lipase Inhibitor II, Proteasome Inhibitor XV, NF-κB Activation Inhibitor IX, MAGL Inhibitor II
      References
      ReferencesLu, Z., et al. 2010. Mol. Cancer 9, 112.
      King, A.R., et al. 2009. Chem. Biol. 16, 1045.
      Tiedemann, R.E., et al. 2009. Blood 113, 4027.
      Yang, H., et al. 2008. J. Cell. Biochem. 103, 234.
      Wu, C.C., et al. 2005. Mol. Cancer Ther. 4, 1277.
      Product Information
      CAS number1258-84-0
      FormRed solid
      Hill FormulaC₃₀H₄₀O₄
      Chemical formulaC₃₀H₄₀O₄
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      S PhraseS: 20-24/25-36/37/39

      When using do not eat or drink.
      Avoid contact with skin and eyes.
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      530070-5MGCN 04055977269352

      Documentation

      Pristimerin - CAS 1258-84-0 - Calbiochem MSDS

      타이틀

      물질안전보건자료(MSDS) 

      Pristimerin - CAS 1258-84-0 - Calbiochem Certificates of Analysis

      TitleLot Number
      530070

      References

      참고문헌 보기
      Lu, Z., et al. 2010. Mol. Cancer 9, 112.
      King, A.R., et al. 2009. Chem. Biol. 16, 1045.
      Tiedemann, R.E., et al. 2009. Blood 113, 4027.
      Yang, H., et al. 2008. J. Cell. Biochem. 103, 234.
      Wu, C.C., et al. 2005. Mol. Cancer Ther. 4, 1277.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision09-August-2010 RFH
      SynonymsMonoacylglycerol Lipase Inhibitor II, Proteasome Inhibitor XV, NF-κB Activation Inhibitor IX, MAGL Inhibitor II
      DescriptionA cell-permeable plant dienone-phenolic triterpenoid, naturally isolated from tripterygium wilfordii, whose inhibitory activities against proteasome chymotrypsin subunit (IC50 = 2.2 and 3.0 µM against purified rabbit 20S and human 26S proteasome, respectively) and cellular NF-κB pathway/IKK activation most likely account for its reported anticancer efficacy both in vitro (IC50 ≤610 nM in A549, K562, KBM5, MCF-7, MDA-MB-231, HepG2, and primary human leukemia cell cultures) and in mice in vivo (1 to 2.5 mg/kg/day, s.c.), including imatinib/STI571-resistant cancer cells harboring Bcr-Abl T315I mutation. Also reported to inhibit the activity of monoacylglycerol lipase (MGL), the enzyme that hydrolyzes and deactivates the cannabionoid receptor ligand 2-Arachidonoyl-sn-glycerol (2-AG), in a reversible manner with high potency (IC50 = 93 nM).
      FormRed solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number1258-84-0
      Chemical formulaC₃₀H₄₀O₄
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (10 mg/ml) or Ethanol (2.5 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesLu, Z., et al. 2010. Mol. Cancer 9, 112.
      King, A.R., et al. 2009. Chem. Biol. 16, 1045.
      Tiedemann, R.E., et al. 2009. Blood 113, 4027.
      Yang, H., et al. 2008. J. Cell. Biochem. 103, 234.
      Wu, C.C., et al. 2005. Mol. Cancer Ther. 4, 1277.